Paper22850751
Overcoming implementation challenges of personalized cancer therapy.
Meric-Bernstam F and 1 other. Nat Rev Clin Oncol, 2012. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. Overcoming implementation challenges of personalized cancer therapy. Papers, record 22850751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22850751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Pharmacogenetics | Major topic |
| Precision Medicine | Major topic |
| Biomarkers, Tumor | |
| Drug Resistance | |
| Genetic Testing | |
| Humans | |
| Proto-Oncogene Proteins B-raf |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA098258 | NCI NIH HHS | United States | P50CA098258 | PubMed and NIH | NIH RePORTER |
| P30CA016672 | NIH | NIH RePORTER |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 23247376 | Complex behaviours--new targets against cancer. | https://conductscience.org/library/papers/23247376 | PubMed |
| Comment in | 23247379 | The microenvironment and resistance to personalized cancer therapy. | https://conductscience.org/library/papers/23247379 | PubMed |
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19596702 | Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. | Ann Oncol | 2009 | https://conductscience.org/library/papers/19596702 | PubMed |
| 2 | 20107891 | Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/20107891 | PubMed |
| 3 | 12629218 | Prospective identification of tumorigenic breast cancer cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12629218 | PubMed |
| 4 | 22397650 | Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22397650 | PubMed |
| 5 | 19920100 | Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19920100 | PubMed |
| 6 | 19861964 | Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19861964 | PubMed |
| 7 | 19844226 | Computational methods for discovering structural variation with next-generation sequencing. | Nat Methods | 2009 | https://conductscience.org/library/papers/19844226 | PubMed |
| 8 | 20406486 | Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032. | J Transl Med | 2010 | https://conductscience.org/library/papers/20406486 | PubMed |
| 9 | 21383736 | Targeting the missing links for cancer therapy. | Nat Med | 2011 | https://conductscience.org/library/papers/21383736 | PubMed |
| 10 | 17599085 | Utilizing RNA interference to enhance cancer drug discovery. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17599085 | PubMed |
| 11 | 20406928 | Future of personalized medicine in oncology: a systems biology approach. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20406928 | PubMed |
| 12 | 20981102 | Distant metastasis occurs late during the genetic evolution of pancreatic cancer. | Nature | 2010 | https://conductscience.org/library/papers/20981102 | PubMed |
| 13 | 17344846 | Patterns of somatic mutation in human cancer genomes. | Nature | 2007 | https://conductscience.org/library/papers/17344846 | PubMed |
| 14 | 11839650 | Expression profile of tyrosine kinases in breast cancer. | Clin Cancer Res | 2002 | https://conductscience.org/library/papers/11839650 | PubMed |
| 15 | 21808265 | The ethical use of mandatory research biopsies. | Nat Rev Clin Oncol | 2011 | https://conductscience.org/library/papers/21808265 | PubMed |
| 16 | 16258065 | Detection and quantification of mutations in the plasma of patients with colorectal tumors. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16258065 | PubMed |
| 17 | 16452222 | Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/16452222 | PubMed |
| 18 | 8616414 | Randomised study of n of 1 trials versus standard practice. | BMJ | 1996 | https://conductscience.org/library/papers/8616414 | PubMed |
| 19 | 18946061 | K-ras mutations and benefit from cetuximab in advanced colorectal cancer. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18946061 | PubMed |
| 20 | 7861872 | Ethics of n-of-1 trials. | Lancet | 1995 | https://conductscience.org/library/papers/7861872 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41906015 | Development and Pre-clinical Feasibility of a Catheter-Based Platform for Interventional Phase-0 Drug Response Measurements. | Ann Biomed Eng | 2026 | https://conductscience.org/library/papers/41906015 | PubMed |
| 40879481 | An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety. | Radiol Imaging Cancer | 2025 | https://conductscience.org/library/papers/40879481 | PubMed |
| 40362682 | Precise Electromagnetic Modulation of the Cell Cycle and Its Applications in Cancer Therapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362682 | PubMed |
| 40156702 | The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines. | Curr Oncol Rep | 2025 | https://conductscience.org/library/papers/40156702 | PubMed |
| 40114099 | Breast cancer treatment modalities, treatment delays, and survival in Brunei Darussalam. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40114099 | PubMed |
| 39552583 | Editorial: design considerations for future personalized vaccination approaches. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/39552583 | PubMed |
| 39036387 | Circulating tumor DNA as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis. | J Natl Cancer Cent | 2024 | https://conductscience.org/library/papers/39036387 | PubMed |
| 38515816 | A nationwide survey of the current status of radiation oncology teaching in Spanish medical schools. | Rep Pract Oncol Radiother | 2023 | https://conductscience.org/library/papers/38515816 | PubMed |
| 38031782 | Computational Approaches: A New Frontier in Cancer Research. | Comb Chem High Throughput Screen | 2024 | https://conductscience.org/library/papers/38031782 | PubMed |
| 36453252 | The EDN1/EDNRA/β‑arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation. | Int J Oncol | 2023 | https://conductscience.org/library/papers/36453252 | PubMed |
| 36379964 | Clinical prospects of WRN inhibition as a treatment for MSI tumours. | NPJ Precis Oncol | 2022 | https://conductscience.org/library/papers/36379964 | PubMed |
| 36330202 | Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis. | Cancer Inform | 2022 | https://conductscience.org/library/papers/36330202 | PubMed |
| 36134201 | Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/36134201 | PubMed |
| 34441402 | Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34441402 | PubMed |
| 34242160 | The Translational and Regulatory Development of an Implantable Microdevice for Multiple Drug Sensitivity Measurements in Cancer Patients. | IEEE Trans Biomed Eng | 2022 | https://conductscience.org/library/papers/34242160 | PubMed |
| 34069200 | Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer-Current Use and Future Opportunities. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34069200 | PubMed |
| 34066940 | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34066940 | PubMed |
| 33033407 | Non-genetic mechanisms of therapeutic resistance in cancer. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/33033407 | PubMed |
| 32740799 | Recent advances on microneedle arrays-mediated technology in cancer diagnosis and therapy. | Drug Deliv Transl Res | 2021 | https://conductscience.org/library/papers/32740799 | PubMed |
| 32160136 | Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey. | JCO Oncol Pract | 2020 | https://conductscience.org/library/papers/32160136 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22850751
GET https://conductscience.org/api/papers/v1/22850751/references?page=2